Vita Coco Company, Inc. (NASDAQ: COCO) disclosed that Chief Executive Officer Martin Roper sold 29,456 shares of the company's common stock across transactions executed from April 10 through April 13, 2026. The disposals generated roughly $1.48 million, with execution prices spanning $50.00 to $51.10 per share.
Separately, a Form 4 filing with the Securities and Exchange Commission shows Roper exercised options to acquire 29,456 shares of Vita Coco common stock at an exercise price of $10.178 per share. The total cash outlay to exercise those options was $299,803.
The share sales were carried out under a Rule 10b5-1 trading plan. After these transactions, Roper directly holds 298,484 shares of Vita Coco common stock. He also retains indirect holdings through family trusts, as noted in the filing.
On the market, Vita Coco's stock is trading at $49.63. That level represents a 58% increase over the past 12 months, while the stock is down 6.4% so far in the current year. Separately, InvestingPro analysis points to a relatively rich valuation at the present price, with shares trading at a price-to-earnings ratio of 45.34 - a valuation note identified among more than a dozen ProTips available to subscribers.
Analyst activity has been notable in recent coverage. Evercore ISI reiterated an Outperform rating on Vita Coco and raised its price target to $70.00, citing strength in sales. The firm referenced scanner data that showed a 51.1% increase in sales for the week ending March 8, and attributed part of the improvement to promotional timing. Evercore ISI also observed that recent political events had not materially altered the company’s freight outlook.
Meanwhile, Morgan Stanley raised its price target for Vita Coco to $57 from $49 while keeping an Equalweight rating. That change followed upward revisions to the firm’s fiscal 2026 and 2027 adjusted EBITDA estimates - increases of 11% and 12%, respectively - which Morgan Stanley applied after reviewing the company’s fourth-quarter results. The firm’s new price target is based on a 21.5 times calendar year 2027 enterprise value-to-EBITDA multiple.
Taken together, the analyst moves reflect a reassessment of near-term sales momentum and margin expectations. The data points cited by Evercore ISI and Morgan Stanley were forward-looking inputs to their models and underpinned the revised targets and estimates.
Investors and observers tracking insider activity will note that the sale and concurrent option exercise leave Roper with a substantial direct stake in the company, along with additional indirect ownership via family trusts. The transactions were executed under a pre-established trading arrangement, and the company’s recent analyst coverage highlights both the sales strength captured in scanner data and valuation metrics that some services view as elevated.